Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 May 25;2016(5):CD006899.
doi: 10.1002/14651858.CD006899.pub3.

Autologous platelet-rich plasma for treating chronic wounds

Maria José Martinez-Zapata  1 , Arturo J Martí-Carvajal, Ivan Solà, José Angel Expósito, Ignasi Bolíbar, Luciano Rodríguez, Joan Garcia, Carlos Zaror
Affiliations
Review

Autologous platelet-rich plasma for treating chronic wounds

Maria José Martinez-Zapata et al. Cochrane Database Syst Rev. .

Abstract

Background: Autologous platelet-rich plasma (PRP) is a treatment that contains fibrin and high concentrations of growth factors with the potential to improve the healing of chronic wounds. This is the first update of a review first published in 2012.

Objectives: To determine whether autologous PRP promotes the healing of chronic wounds.

Search methods: In June 2015, for this first update, we searched the Cochrane Wounds Specialised Register; the Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library): Ovid MEDLINE; Ovid MEDLINE (In-Process & Other Non-Indexed Citations); Ovid EMBASE; and EBSCO CINAHL. We also searched for ongoing and unpublished clinical trials in the WHO International Clinical Trials Registry Platform (ICTRP) (searched January 2015). We did not impose any restrictions with respect to language, date of publication, or study setting.

Selection criteria: We included randomised controlled trials (RCTs) that compared autologous PRP with placebo or alternative treatments for any type of chronic wound in adults. We did not apply any date or language restrictions.

Data collection and analysis: We used standard Cochrane methodology, including two reviewers independently selecting studies for inclusion, extracting data, and assessing risk of bias.

Main results: The search identified one new RCT, making a total of 10 included RCTs (442 participants, 42% women). The median number of participants per RCT was 29 (range 10 to 117). Four RCTs recruited people with a range of chronic wounds; three RCTs recruited people with venous leg ulcers, and three RCTs considered foot ulcers in people with diabetes. The median length of treatment was 12 weeks (range 8 to 40 weeks).It is unclear whether autologous PRP improves the healing of chronic wounds generally compared with standard treatment (with or without placebo) (risk ratio (RR) 1.19, 95% confidence interval (CI) 0.95 to 1.50; I(2) = 27%, low quality evidence, 8 RCTs, 391 participants). Autologous PRP may increase the healing of foot ulcers in people with diabetes compared with standard care (with or without placebo) (RR 1.22, 95% CI 1.01 to 1.49; I(2) = 0%, low quality evidence, 2 RCTs, 189 participants). It is unclear if autologous PRP affects the healing of venous leg ulcers (RR 1.02, 95% CI 0.81 to 1.27; I(2) = 0% ). It is unclear if there is a difference in the risk of adverse events in people treated with PRP or standard care (RR 1.05, 95% CI 0.29 to 3.88; I(2) = 0%, low quality evidence from 3 trials, 102 participants).

Authors' conclusions: PRP may improve the healing of foot ulcers associated with diabetes, but this conclusion is based on low quality evidence from two small RCTs. It is unclear whether PRP influences the healing of other chronic wounds. The overall quality of evidence of autologous PRP for treating chronic wounds is low. There are very few RCTs evaluating PRP, they are underpowered to detect treatment effects, if they exist, and are generally at high or unclear risk of bias. Well designed and adequately powered clinical trials are needed.

PubMed Disclaimer

Conflict of interest statement

Maria José Martinez‐Zapata: None.

Arturo J Martí‐Carvajal: Arturo J Martí‐Carvajal was employed in by Eli Lilley in 2004 and Merck in 2007 to run workshops on the critical appraisal of clinical trials. This activity was not related to his work with Cochrane or any Cochrane review.

Ivan Solà: None.

José Angel Expósito: None.

Ignasi Bolíbar: None.

Luciano Rodríguez: None.

Joan Garcia: None.

Carlos Zaro: None.

Figures

1
1
Study flow diagram.
2
2
Methodological quality graph: review authors' judgments about each methodological quality item presented as percentages across all included studies.
3
3
Methodological quality summary: review authors' judgments about each methodological quality item for each included study.
1.1
1.1. Analysis
Comparison 1 PRP versus standard care (with/without placebo), Outcome 1 Chronic wounds completely healed.
1.2
1.2. Analysis
Comparison 1 PRP versus standard care (with/without placebo), Outcome 2 Total area epithelialised (cm2).
1.3
1.3. Analysis
Comparison 1 PRP versus standard care (with/without placebo), Outcome 3 Percentage of wound area healed.
1.4
1.4. Analysis
Comparison 1 PRP versus standard care (with/without placebo), Outcome 4 Wound complications.
1.5
1.5. Analysis
Comparison 1 PRP versus standard care (with/without placebo), Outcome 5 Adverse events.
2.1
2.1. Analysis
Comparison 2 Subgroup analysis: PRP releasate/lysate versus standard care (with/without placebo), Outcome 1 Chronic wounds completely healed.
3.1
3.1. Analysis
Comparison 3 PRP plus protease‐modulating matrix (PMM) versus PMM, Outcome 1 Chronic wounds completely healed.
See this image and copyright information in PMC

Update of

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

References to studies included in this review

Anitua 2008 {published data only}
    1. Aguirre JJ, Francisco S, Cabezas A, Calleja A, Ayerdi E, Pena MA, et al. Randomized open‐label controlled pilot trial to evaluate the effectiveness of PRGF in the treatment of chronic cutaneous ulcers: results at 4 weeks of follow‐up. [Ensayo clínico piloto, aleatorizado, en grupos paralelos, ciego y controlado con tratamiento convencional para evaluar la eficacia de plasma rico en factores de crecimiento en el tratamiento de las úlceras cutáneas: resultados a las 4 semanas de seguimiento]. XIX Congreso de la Sociedad Española de Farmacología Clínica 2004:Abstract 19.
    1. Anitua E, Aguirre JJ, Algorta J, Ayerdi E, Cabezas AI, Orive G, et al. Effectiveness of autologous preparation rich in growth factors for the treatment of chronic cutaneous ulcers. Journal of Biomedical Materials Research ‐ Part B Applied Biomaterials 2008;84(2):415‐21. - PubMed
Driver 2006 {published data only}
    1. Driver VR, Hanft J, Fylling CP, Beriou JM, Autologel Diabetic Foot Ulcer Study Group. A prospective, randomized, controlled trial of autologous platelet‐rich plasma gel for the treatment of diabetic foot ulcers. Ostomy/Wound Management 2006;52(6):68‐87. - PubMed
Kakagia 2007 {published data only}
    1. Kakagia D, Kazakos K, Xarchas K, Karanikas M, Georgiadis G, Tripsiannis G, et al. Synergistic action of protease‐modulating matrix and autologous growth factors in healing diabetic foot ulcers. A prospective randomized trial. Journal of Diabetes and its Complications 2007;21(6):387‐91. - PubMed
Knighton 1990 {published data only}
    1. Knighton DR, Ciresi K, Fiegel VD, Schumerth S, Butler E, Cerra F. Stimulation of repair in chronic, nonhealing, cutaneous ulcers using platelet‐derived wound healing formula. Surgery, Gynecology and Obstetrics 1990;170(1):56‐60. - PubMed
    1. Knighton DR, Doucette M, Fiegel VD, Ciresi K, Butler E, Austin L. The use of platelet derived wound healing formula in human clinical trials. Progress in Clinical and Biological Research 1988;266:319‐29. - PubMed
Krupski 1991 {published data only}
    1. Krupski WC, Reilly LM, Perez S, Moss KM, Crombleholme PA, Rapp JH. A prospective randomized trial of autologous platelet‐derived wound healing factors for treatment of chronic nonhealing wounds: a preliminary report. Journal of Vascular Surgery 1991;14(4):526‐32. - PubMed
Li 2012 {published data only}
    1. Li L, Wang C, Wang Y, He LP, Yang YZ, Chen LH, et al. Impact of topical application of autologous platelet‐rich gel on medical expenditure and length of stay in hospitals in diabetic patients with refractory cutaneous ulcers. Sichuan Da Xue Xue Bao Yi Xue Ban 2012;43(5):762‐5. - PubMed
Planinsek Rucigaj 2007 {published data only}
    1. Planinsek Rucigaj T, Lunder T. Stimulation of venous leg ulcers with thrombocytic growth factors: A randomised study. Proceedings of the 17th Conference of the European Wound Management Association. Glasgow, UK: European Wound Healing Association, 2007:Abstract 93.
Senet 2003 {published data only}
    1. Senet P, Bon FX, Benbunan M, Bussel A, Traineau R, Calvo F. Randomized trial and local biological effect of autologous platelets used as adjuvant therapy for chronic venous leg ulcers. Journal of Vascular Surgery 2003;38(6):1342‐8. - PubMed
Stacey 2000 {published data only}
    1. Stacey MC, Mata SD, Trengove NJ, Mather CA. Randomised double‐blind placebo controlled trial of topical autologous platelet lysate in venous ulcer healing. European Journal of Vascular and Endovascular Surgery 2000;20(3):296‐301. - PubMed
Weed 2004 {published data only}
    1. Weed B, Davis MDP, Felty CL, Liedl DA, Pineda AA, Moore SB, et al. Autologous platelet lysate product versus placebo in patients with chronic leg ulcerations: a pilot study using a randomized, double‐blind, placebo‐controlled trial. Wounds: A Compendium of Clinical Research and Practice 2004;16(9):273‐82.

References to studies excluded from this review

Afshari 2005 {published data only}
    1. Afshari M, Larijani B, Fadayee M, Darvishzadeh F, Ghahary A, Pajoui M, et al. Efficacy of topical epidermal growth factor in healing diabetic foot ulcers. Therapy 2005;2(5):759‐65.
Aminian 2000 {published data only}
    1. Aminian B, Shams M, Soveyd M, Omrani GR. Topical autologous platelet‐derived growth factors in the treatment of chronic diabetic ulcers. Archives of Iranian Medicine 2000;3(2):55‐9.
Aminian 2011 {published data only}
    1. Aminian B, Shams M, Karim‐Aghaee B, Soveyd M, Omrani GR. Tha role of autologous derived growth factor in the management of decubitus ulcers. www.ams.ac.ir/AIM/9922/aminian9922.html (accessed 2 March 2016).
Atri 1990 {published data only}
    1. Atri SC, Misra J, Bisht D, Misra K. Use of homologous platelet factors in achieves total healing of recalcitrant skin ulcers. Surgery 1990;108(3):508‐12. - PubMed
Carter 2011 {published data only}
    1. Carter MJ, Fylling CP, Li WW, Leon J, Driver VR, Serena TE, et al. Analysis of run‐in and treatment data in a wound outcomes registry: Clinical impact of topical platelet‐rich plasma gel on healing trajectory. International Wound Journal 2011;8 (6 ):638‐50. - PMC - PubMed
Cervelli 2012 {published data only}
    1. Cervelli V, Nicoli F, Spallone D, Verardi S, Sorge R, Nicoli M, et al. Treatment of traumatic scars using fat grafts mixed with platelet‐rich plasma, and resurfacing of skin with the 1540 nm nonablative laser. Clinical and Experimental Dermatology 2012 ;37 (1 ):55‐61. - PubMed
Chen 2010 {published data only}
    1. Chen TM, Tsai J‐C, Burnouf T. A novel technique combining platelet gel, skin graft, and fibrin glue for healing recalcitrant lower extremity ulcers. Dermatologic Surgery 2010;36(4):453‐60. - PubMed
Crovetti 2004 {published data only}
    1. Crovetti G, Martinelli G, Issi M, Barone M, Guizzardi M, Campanati B, et al. Platelet gel for healing cutaneous chronic wounds. Transfusion and Apheresis Science 2004;30:145–51. - PubMed
Danielsen 2008 {published data only}
    1. Danielsen P, Jorgensen B, Karlsmark T, Jorgensen LN, Agren MS. Effect of topical autologous platelet‐rich fibrin versus no intervention on epithelialization of donor sites and meshed split‐thickness skin autografts: a randomized clinical trial. Plastic and Reconstructive Surgery 2008;122(5):1431‐40. - PubMed
    1. Danielsen P, Jorgensen B, Karlsmark T, Jorgensen LN, Agren MS. Effects of locally applied autologous platelet‐rich fibrin on split thickness skin graft donor sites. Proceedings of the 16th Conference of the European Wound Management Association; Prague, Czech Republic; 18‐20 May, 2006. Poster 083. Prague.
Enriquez‐Vega 2012 {published data only}
    1. Enriquez‐Vega ME, Bobadilla‐Flores NO, Rodriguez‐Jimenez OA, Guerra‐Marquez A, Carrasco‐Nava L, Varela‐Silva J. Platelet rich plasma for the treatment of ischemic ulcers in diabetic patients. Revista Mexicana de Angiologia 2012;40(2):51‐6.
Greppi 2011 {published data only}
    1. Greppi N, Mazzucco L, Galetti G, Bona F, Petrillo E, Smacchia C, et al. Treatment of recalcitrant ulcers with allogeneic platelet gel from pooled platelets in aged hypomobile patients. Biologicals 2011;39 (2):73‐80. - PubMed
Hao 2010 {published data only}
    1. Hao T, Zhu J, Hu W, Zhang H, Gao Z, Wen X, et al. Autogenous platelet‐rich plasma gel with acellular xenogeneic dermal matrix for treatment of deep II degree burns. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 2010;24(6):647‐9. - PubMed
Holloway 1993 {published data only}
    1. Holloway GA, Steed DL, DeMarco MJ, Masumoto T, Moosa HH, Webster MW, et al. A randomized,controlled dose response trial of activated platelet supernatant, topical CT‐102 in chronic, nonhealing diabetic wounds. Wounds 1993;5(4):198–206.
Jaiswal 2010 {published data only}
    1. Jaiswal SS, Gambhir RPS, Agrawal A, Harish S. Efficacy of topical recombinant human platelet derived growth factor on wound healing in patients with chronic diabetic lower limb ulcers. Indian Journal of Surgery 2010;72(1):31‐5. - PMC - PubMed
Jorgensen 2011 {published data only}
    1. Jorgensen B, Karlsmark T, Vogensen H, Haase L, Lundquist R. A pilot study to evaluate the safety and clinical performance of Leucopatch, an autologous, additive‐free, platelet‐rich fibrin for the treatment of recalcitrant chronic wounds. International Journal of Lower Extremity Wounds 2011;10(4):218‐23. - PubMed
JPRN‐UMIN000009860 {published data only}
    1. JPRN‐UMIN000009860. Treatment of cutaneous ulcer using platelet‐rich plasma. apps.who.int/trialsearch/Trial2.aspx?TrialID=JPRN‐UMIN000009860 (accessed 2 March 2016).
JPRN‐UMIN000015689 {published data only}
    1. JPRN‐UMIN000015689. An exploratory clinical trial using platelet‐rich plasma in patients with chronic skin ulcers. apps.who.int/trialsearch/Trial2.aspx?TrialID=JPRN‐UMIN000015689 (accessed 2 March 2016).
Khandelwal 2013 {published data only}
    1. Khandelwal S, Chaudhary P, Poddar DD, Saxena N, Singh RA, Biswal UC. Comparative study of different treatment options of grade III and IV diabetic foot ulcers to reduce the incidence of amputations. Clinical Practice 2013;3(1):e9. - PMC - PubMed
Knighton 1986 {published data only}
    1. Knighton DR, Fiegel VD, Austin LL, Butler EL. Classification and treatment of chronic non‐healing wounds. Annals of Surgery 1986;204(3):322‐30. - PMC - PubMed
Köveker 1992 {published data only}
    1. Köveker G, Coerper S, Tolksdorf A, Becker HD. Clinical experience with platelet‐derived wound healing factors (PDWHF) in venous leg ulcers. Proceedings of the 5th Annual Symposium on Advanced Wound Care; 1992, 23‐25 April; New Orleans, Lousiana. 1992:63.
Ma 2007 {published data only}
    1. Ma B, Cheng DS, Xia ZF, Ben DF, Lu W, Cao ZF, et al. Randomized, multicenter, double‐blind, and placebo‐controlled trial using topical recombinant human acidic fibroblast growth factor for deep partial‐thickness burns and skin graft donor site. Wound Repair and Regeneration 2007;15(6):795–9. - PubMed
Margolis 2001 {published data only}
    1. Margolis DJ, Kantor J, Santanna J, Strom BL, Berlin JA. Effectiveness of platelet releasate for the treatment of diabetic neuropathic foot ulcers. Diabetes Care 2001;24(3):483‐8. - PubMed
Mazzuco 2004 {published data only}
    1. Mazzucco L, Medici D, Serra M, Panizza R, Rivara G, Orecchia S. The use of autologous platelet gel to treat difficult‐to‐heal wounds: a pilot study. Transfusion 2004;44(7):1013‐8. - PubMed
Morimoto 2015 {published data only}
    1. Morimoto N, Kakudo N, Matsui M, Ogura T, Hara T, Suzuki K, et al. Exploratory clinical trial of combination wound therapy with a gelatin sheet and platelet‐rich plasma in patients with chronic skin ulcers: study protocol. BMJ Open 2015;5(5):e007733. [DOI: 10.1136/bmjopen-2015-007733] - DOI - PMC - PubMed
NCT00215735 {published data only}
    1. NCT00215735. Effect of platelet concentrate in treatment of diabetic ulcers. clinicaltrials.gov/ct2/show/NCT00215735 (accessed 2 March 2016).
NCT00273234 {published data only}
    1. NCT00273234. Clinical effectiveness of topical autologous platelet gel for the treatment of venous ulcers. clinicaltrials.gov/ct2/show/NCT00273234 (accessed 2 March 2016).
NCT00338702 {published data only}
    1. NCT00338702. A randomized, controlled trial of autologous platelet gel treatment in diabetic foot ulcers. clinicaltrials.gov/ct2/show/NCT00338702 (accessed 2 March 2016).
NCT00762138 {published data only}
    1. NCT00762138. The AutoloGel™ Post‐Market Surveillance (TAPS) Program. clinicaltrials.gov/ct2/show/NCT00762138 (accessed 2 March 2016).
NCT00856934 {published data only}
    1. NCT00856934. Effect of platelet rich plasma and keratinocyte suspensions on wound healing. clinicaltrials.gov/ct2/show/NCT00856934 (accessed 2 March 2016).
NCT01553955 {published data only}
    1. NCT01553955. Efficacy of training in preparation of platelet rich plasma using a standard centrifuge and manual pipetting methods. clinicaltrials.gov/show/NCT01553955 (accessed 2 March 2016).
NCT01639144 {published data only}
    1. NCT01639144. Use of platelet‐rich plasma (PRP) and platelet‐poor plasma (PPP) to prevent infection and delayed wound healing after elective foot and ankle surgery in healthy adults. apps.who.int/trialsearch/Trial2.aspx?TrialID=NCT016391 (accessed 2 March 2016).
NCT02071979 {published data only}
    1. NCT02071979. Registry trial of the effectiveness of platelet rich plasma for chronic non‐healing wounds (CMS). www.clinicaltrials.gov/ct2/show/NCT02071979?term=NCT02071979&rank=1 (accessed 2 March 2016).
NCT02088268 {published data only}
    1. NCT02088268. Treatment of PRP on diabetes wound. www.clinicaltrials.gov/ct2/show/NCT02088268?term=NCT02088268&rank=1 (accessed 2 March 2016).
Niezgoda 2005 {published data only}
    1. Niezgoda JA, Gils CC, Frykberg RG, Hodde JP. Randomized clinical trial comparing OASIS wound matrix to Regranex gel for diabetic ulcers. Advances in Skin and Wound Care 2005;18(5):258‐66. - PubMed
Reutter 1999 {published data only}
    1. Reutter H, Bort S, Jung MF, Klyscz T, Schippert W, Zuder D, et al. Questionable effectiveness of autologous platelet growth factors (PDWHF) in treatment of venous ulcers of the leg. Hautarzt 1999;50(12):859‐65. - PubMed
Saad Setta 2011 {published data only}
    1. Saad Setta H, Elshahat A, Elsherbiny K, Massoud K, Safe I. Platelet‐rich plasma versus platelet‐poor plasma in the management of chronic diabetic foot ulcers: a comparative study. International Wound Journal 2011;8(3):307‐12. - PMC - PubMed
Saldamalacchia 2004 {published data only}
    1. Saldalamacchia G, Lapice E, Cuomo V, Feo E, D'Agostino E, Rivellese AA, et al. A controlled study of the use of autologous platelet gel for the treatment of diabetic foot ulcers. Nutrition, Metabolism, and Cardiovascular Disease 2004;14(6):395‐6. - PubMed
Sánchez 2007 {published data only}
    1. Sánchez M, Anitua E, Azofra J, Andía I, Padilla S, Mujika I. Comparison of surgically repaired Achilles tendon tears using platelet‐rich fibrin matrices. American Journal of Sports Medicine 2007;35(2):245‐51. - PubMed
Scevola 2010 {published data only}
    1. Scevola S, Nicoletti G, Brenta F, Isernia P, Maestri M, Faga A. Allogenic platelet gel in the treatment of pressure sores: A pilot study. International Wound Journal 2010;7(3):184‐90. - PMC - PubMed
Soula 2012 {published data only}
    1. Soula O, Seroussi C, Desort‐Henin V, Correia J, Soula R, Soula G, et al. Phase I/II results of innovative PDGF‐BB formulation with improved compliance at low‐cost for the treatment of diabetic foot ulcer. EWMA Journal 2012;12(2):91.
Steed 1992 {published data only}
    1. Steed DL, Goslen JB, Holloway GA, Malone JM, Bunt TJ, Webster MW. Randomized prospective double‐blind trial in healing chronic diabetic foot ulcers. CT‐102 activated platelet supernatant, topical versus placebo. Diabetes Care 1992;15(11):1598‐604. - PubMed
Steed 1993 {published data only}
    1. Steed DL. Growth factors in the treatment of diabetic foot ulcers. Wounds: A Compendium of Clinical Research and Practice 1993;5(2):80‐3.
Steed 1996 {published data only}
    1. Steed DL, Edington HD, Webster MW. Recurrence rate of diabetic neurotrophic foot ulcers healed using topical application of growth factors released from platelets. Wound Repair and Regeneration 1996;4(2):230‐3. - PubMed
Steinbaum 1994 {published data only}
    1. Steinbaum SS, Cucinell S, Hathaway TK. Effects of cryoprecipitate on the healing of chronic wounds. Military Medicine 1994;159(2):105‐8. - PubMed
Tarpila 1998 {published data only}
    1. Tarpila E, Jergovic D, Sjoberg F, Bjornsson A, Abildgard L, Rosseau A. Autologous platelet‐derived wound healing factors in the treatment of leg ulcers with split‐skin grafts. European Wound Management Association Conference 1998. Harrogate, UK: European Wound Management Association, 1998:81‐5.

References to studies awaiting assessment

Obolenskiy 2014 {published data only}
    1. Obolenskiy VN, Ermolova A, Laberko A, Semenova TV. Efficacy of platelet‐rich plasma for the treatment of chronic wounds. European Wound Management Association Journal 2014;14(1):37‐41.
Serra 2014 {published data only}
    1. Serra R, Grande R, Butrico L, Montemurro R, Caridi G, Fugetto F, et al. Skin grafting and topical application of platelet gel in the treatment of vascular lower extremity ulcers. Acta Phlebologica 2014;15(3):129‐36.

References to ongoing studies

ChiCTR‐TRC‐00000325 {published data only}
    1. ChiCTR‐TRC‐00000325. A prospective, randomized, controlled trial of autologous platelet‐rich plasma gel to treat refractory dermal ulcer. www.chictr.org/en/proj/show.aspx?proj=1072 (accessed 2 March 2016).
IRCT2014060415574N3 {published data only}
    1. IRCT2014060415574N3. Effect of platelet dressing on the healing of diabetic foot ulcers compared with routine dressing in patients with diabetic foot ulcers ‐ Shahid Beheshti Hospital. www.irct.ir/searchresult.php?id=15574&number=3 (accessed 2 March 2016).
ISRCTN84928077 {published data only}
    1. ISRCTN84928077. Randomised controlled trial of platelet rich plasma biotherapies in the management of adult patients with recalcitrant and slow healing wounds following major trauma. isrctn.com/ISRCTN84928077 (accessed 2 March 2016).
JPRN‐UMIN000004840 {published data only}
    1. JPRN‐UMIN000004840. Clinical study for the treatment of chronic wounds using Platelet‐rich Plasma. apps.who.int/trialsearch/Trial2.aspx?TrialID=JPRN‐UMIN000004840 (accessed 2 March 2016).
NCT00658983 {published data only}
    1. NCT00658983. Autologous platelet enriched gel versus metalloproteinase inhibitor in the healing of chronic lower leg ulcers. clinicaltrials.gov/show/NCT00658983 (accessed 2 March 2016).
NCT02209662 {published data only}
    1. NCT02209662. Safety and efficacy study of APIC‐PRP in non‐healing diabetic foot ulcers. www.clinicaltrials.gov/ct2/show/NCT02209662?term=NCT02209662&rank=1 (accessed 2 March 2016).
NCT02213952 {published data only}
    1. NCT02213952. PRP ULCERAS: Clinical trial phase III (PRPULCERAS). clinicaltrials.gov/ct2/show/NCT02213952 (accessed 2 March 2016).
    1. San Sebastian KM, Lobato I, Hernández I, Burgos‐Alonso N, Gomez‐Fernandez M, López J, et al. Efficacy and safety of autologous platelet rich plasma for the treatment of vascular ulcers in primary care: Phase III study. BMC Family Practice 2014;15:211. - PMC - PubMed
NCT02307448 {published data only}
    1. NCT02307448. Effectiveness of autologous platelet rich plasma in the treatment of chronic non‐healing wounds. www.clinicaltrials.gov/ct2/show/NCT02307448?term=NCT02307448&rank=1 (accessed 2 March 2016).
NCT02312518 {published data only}
    1. NCT02312518. Clinical trial of ECLIPSE PRP™ Wound Biomatrix in chronic non‐healing venous leg ulcers. www.clinicaltrials.gov/ct2/show/NCT02312518?term=NCT02312518&rank=1 (accessed 2 March 2016).

Additional references

Anitua 2004
    1. Anitua E, Andia I, Ardanza B, Nurden P, Nurden AT. Autologous platelets as a source of proteins for healing and tissue regeneration. Thrombosis and Haemostasis 2004;91(1):4‐15. - PubMed
Barbenel 1977
    1. Barbenel JC, Jordan MM, Nicol SM, Clark MO. Incidence of pressure‐sores in the Greater Glasgow Health Board area. Lancet 1977;2(8037):548‐50. - PubMed
Bennett 2004
    1. Bennett G, Dealey C, Posnett J. The cost of pressure ulcers in the UK. Age and Ageing 2004;33(3):230‐5. - PubMed
Crovetti 2005
    1. Crovetti G, Martinelli G, Issi M, Barone M, Guizzardi M, Campanati B, et al. Autologous platelet gel applications during cardiovascular surgery: effect on wound healing. Journal of Extra‐Corporeal Technology 2005;37(2):148‐52. - PMC - PubMed
de la Torre 2015
    1. Torre J. Chronic wounds. emedicine.medscape.com/article/1298452‐overview#a1 (accessed 2 March 2016).
DerSimonian 1986
    1. DerSimonian R, Laird N. Meta‐analysis in clinical trials. Controlled Clinical Trials 1986;7(3):177‐88. - PubMed
Ebbeskog 1996
    1. Ebbeskog B, Lindholm C, Ohman S. Leg and foot ulcer patients. Epidemiology and nursing care in an urban population in south Stockholm, Sweden. Scandinavian Journal of Primary Health Care 1996;14(4):238‐43. - PubMed
Edwards 2002
    1. Edwards J, Stapley S. Debridement of diabetic foot ulcers. Cochrane Database of Systematic Reviews 2010, Issue 1. [DOI: 10.1002/14651858.CD003556.pub2] - DOI - PMC - PubMed
FDA 2005
    1. US Dept of Health and Human Services, Food, Drug Administration (FDA). Guidance for industry: chronic cutaneous ulcer and burn wounds‐developing products for treatment. www.fda.gov/cber/guidelines.htm (accessed 2 March 2016).
Gonzalez 2000
    1. Gonzalez ER, Oley MA. The management of lower‐extremity diabetic ulcers. Managed Care Interface 2000;13(11):80‐7. - PubMed
Graham 2003
    1. Graham ID, Harrison MB, Nelson EA, Lorimer K, Fisher A. Prevalence of lower‐limb ulceration: a systematic review of prevalence studies. Advances in Skin and Wound Care 2003;16(6):305‐16. - PubMed
Grey 2006
    1. Grey JE, Harding KG, Enoch S. Pressure ulcers. BMJ 2006;332(7539):472‐5. - PMC - PubMed
Higgins 2011a
    1. Higgins JPT, Altman DG, Sterne JAC (editors). Chapter 8: Assessing risk of bias. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org.
Higgins 2011b
    1. Higgins JPT, Altman DG (editors). Chapter 9: Analysing data and undertaking meta‐analyses. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org.
Higgins 2011c
    1. Higgins JPT, Deeks JJ, Altman DG (editors). Chapter 16: Special topics in statistics. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org.
Kaltenthaler 2001
    1. Kaltenhaler E, Whitfield, Walters SJ, Akehurst RL, Paisley S. UK, USA and Canada: how do their pressure ulcer prevalence and incidence data compare?. Journal of Wound Care 2001;10(1):530‐5. - PubMed
Knighton 1988
    1. Knighton DR, Doucette M, Fiegel VD, Ciresi K, Butler E, Austin L. The use of platelet derived wound healing formula in human clinical trials. Progress in Clinical and Biological Research 1988;266:319‐29. - PubMed
Kumar 2004
    1. Kumar RN, Gupchup GV, Dodd MA, Shah B, Iskedjian M, Einarson TR, et al. Direct health care costs of 4 common skin ulcers in New Mexico Medicaid fee‐for‐service patients. Advances in Skin and Wound Care 2004;17(3):143‐9. - PubMed
Lacci 2010
    1. Lacci KM, Dardik A. Platelet‐rich plasma: support for its use in wound healing. Yale Journal of Biology and Medicine 2010;83(1):1‐9. - PMC - PubMed
Langedam 2013
    1. Langendam MW, Aki EA, Dahm P, Glasziou P, Guyatt G, Schunemann HJ. Assessing and presenting summaries of evidence in Cochrane Reviews. Systematic Reviews 2013;2:81. - PMC - PubMed
Langer 2003
    1. Langer G, Schloemer G, Knerr A, Kuss O, Behrens J. Nutritional interventions for preventing and treating pressure ulcers. Cochrane Database of Systematic Reviews 2003, Issue 4. [DOI: 10.1002/14651858.CD003216] - DOI - PubMed
Lavery 2003
    1. Lavery LA, Armstrong DG, Wunderlich RP, Tredwell J, Boulton AJ. Diabetic foot syndrome: evaluating the prevalence and incidence of foot pathology in Mexican Americans and non‐Hispanic whites from a diabetes disease management cohort. Diabetes Care 2003;26(5):1435‐8. - PubMed
Lefebvre 2011
    1. Lefebvre C, Manheimer E, Glanville J. Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org.
Mao 2010
    1. Mao CL, Rivet AJ, Sidora T, Pasko MT. Update on pressure ulcer management and deep tissue injury. Annals of Pharmacotherapy 2010;44(2):325‐32. - PubMed
Marlovits 2004
    1. Marlovits S, Mousavi M, Gäbler C, Erdös J, Vécsei V. A new simplified technique for producing platelet‐rich plasma: A short technical note. European Spine Journal 2004;13(Suppl 1):102‐6. - PMC - PubMed
Martinez‐Zapata 2009
    1. Martínez‐Zapata MJ, Martí‐Carvajal A, Solà I, Bolibar I, Angel Expósito J, Rodriguez L, et al. Efficacy and safety of the use of autologous plasma rich in platelets for tissue regeneration: a systematic review. Transfusion 2009;49(1):44‐56. - PubMed
Marx 2004
    1. Marx RE. Platelet‐rich plasma: evidence to support its use. Journal of Oral and Maxillofacial Surgery 2004;62(4):489‐96. - PubMed
Moffat 2004
    1. Moffat CJ, Franks PJ, Doherty DC, Martin R, Blewett R, Ross F. Prevalence of leg ulcers in a London population. QJM 2004;97(7):431‐7. - PubMed
Moher 2009
    1. Moher D, Liberati A, Tetzlaff J, Altman DG. PRISMA Group. Preferred reporting items for systematic reviews and meta‐analyses: the PRISMA statement. J Clin Epidemiol 2009;62(10):1006‐12. - PubMed
Moore 2005
    1. Moore ZE, Cowman S. Wound cleansing for pressure ulcers. Cochrane Database of Systematic Reviews 2005, Issue 4. [DOI: 10.1002/14651858.CD004983.pub2] - DOI - PubMed
Munirah 2007
    1. Munirah S, Samsudin OC, Chen HC, Sharifah Salmah SH, Aminuddin BS, Ruszymah BHI. Articular cartilage restoration in load‐bearing osteochondral defects by implantation of autologous chondrocyte‐fibrin constructs. Journal of Bone and Joint Surgery 2007;89(8):1099‐109. - PubMed
O'Meara 2009a
    1. O'Meara S, Tierney J, Cullum N, Bland JM, Franks PJ, Mole T, et al. Four layer bandage compared with short stretch bandage for venous leg ulcers: systematic review and meta‐analysis of randomised controlled trials with data from individual patients. BMJ 2009;338:b1344. - PMC - PubMed
O'Meara 2009b
    1. O'Meara S, Cullum NA, Nelson EA. Compression for venous leg ulcers. Cochrane Database of Systematic Reviews 2009, Issue 1. [DOI: 10.1002/14651858.CD000265.pub2] - DOI - PubMed
Reiber 1996
    1. Reiber GE. The epidemiology of diabetic foot problems. Diabetic Medicine 1996;13(Suppl 1):6‐11. - PubMed
Reiber 2001
    1. Reiber GE. Epidemiology of foot ulcers and amputations in the diabetic foot. In: Bowker JH, Pfeifer MA editor(s). The Diabetic Foot. St Louis, Mo: Mosby, 2001:13‐32.
RevMan 2014 [Computer program]
    1. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
Robinson 1993
    1. Robinson CJ. Growth factors: therapeutic advances in wound healing. Annals of Medicine 1993;25:535‐8. - PubMed
Rodrigues 2006
    1. Rodrigues I, Mégie MF. Prevalence of chronic wounds in Quebec home care: an exploratory study. Ostomy/Wound Management 2006;52(5):46‐8, 50, 52‐7. - PubMed
Scriven 1998
    1. Scriven JM, Taylor LE, Wood AJ, Bell PRF, Naylor AR, London NJM . A prospective randomised trial of four‐layer versus short stretch compression bandages for the treatment of venous leg ulcers . Annals of the Royal College of Surgeons of England 1998;80(3):215‐20. - PMC - PubMed
SIGN 2015
    1. Scottish Intercollegiate Guidelines Network (SIGN). Search filters. www.sign.ac.uk/methodology/filters.html#random (accessed 23 May 2015).
Singh 2005
    1. Singh N, Armstrong DG, Lipsky BA. Preventing foot ulcers in patients with diabetes. JAMA 2005;293(2):217‐28. - PubMed
Spencer 2000
    1. Spencer S. Pressure relieving interventions for preventing and treating diabetic foot ulcers. Cochrane Database of Systematic Reviews 2000, Issue 3. [DOI: 10.1002/14651858.CD002302] - DOI - PubMed
Sterne 2011
    1. Sterne JAC, Egger M, Moher D (editors). Chapter 10: Addressing reporting bias. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. Available from www.cochrane‐handbook.org.
Vas 2008
    1. Vas J, Modesto M, Mendez C, Perea‐Milla E, Aguilar I, Carrasco‐Lozano JM, et al. Effectiveness of acupuncture, special dressings and simple, low‐adherence dressings for healing venous leg ulcers in primary healthcare: study protocol for a cluster‐randomized open‐labeled trial. BMC Complementary and Alternative Medicine 2008;8:29. [DOI: 10.1186/1472-6882-8-29] - DOI - PMC - PubMed
Villela 2010
    1. Villela DL, Santos VL. On the use of platelet‐rich plasma for diabetic ulcer: a systematic review. Growth Factors 2010;28(2):111‐6. - PubMed
Yuan 2009
    1. Yuan NB, Long Y, Zhang XX, Ran XW. Study on the mechanism of autologous platelet‐rich gel to treat the refractory diabetic dermal. Sichuan Da Xue Xue Bao Yi Xue Ban 2009;40(2):292‐4. - PubMed

References to other published versions of this review

Martinez‐Zapata 2008
    1. Martinez‐Zapata MJ, Martí‐Carvajal AJ, Solà I, Exposito JA, Bolivar I, Rodríguez L, et al. Autologous platelet‐rich plasma for treating chronic wounds. Cochrane Database of Systematic Reviews 2008, Issue 1. [DOI: 10.1002/14651858.CD006899.pub2] - DOI - PubMed
Martinez‐Zapata 2012
    1. Martinez‐Zapata MJ, Martí‐Carvajal AJ, Solà I, Expósito JA, Bolíbar I, Rodríguez L, et al. Autologous platelet‐rich plasma for treating chronic wounds. Cochrane Database of Systematic Reviews 2012, Issue 10. [DOI: 10.1002/14651858.CD006899.pub2] - DOI - PubMed